BACKGROUND
Electrum
We are a blank check company incorporated in the British Virgin Islands on December 12, 2014 as a business company with limited liability for the purpose of acquiring, engaging in a share exchange, share reconstruction and amalgamation, purchasing all or substantially all of the assets of, entering into contractual arrangements, or engaging in any other similar business combination with one or more businesses or entities.
On June 10, 2015, we consummated our IPO of 20,000,000 units, including the partial exercise of the underwriters’ over-allotment option of 2,500,000 units, with each unit consisting of one ordinary share and one warrant to purchase one half of one ordinary share. The units were sold at an offering price of $10.00 per unit, generating gross proceeds of $200,000,000.
The units began trading on June 11, 2015 on the NASDAQ Capital Market under the symbol “ELECU.” Commencing on August 12, 2015, the securities comprising the units began separately trading. The units, ordinary shares, and warrants are trading on the NASDAQ Stock Market under the symbols “ELECU,” “ELEC” and “ELECW,” respectively.
Prior to our IPO, our sponsor purchased an aggregate of 3,737,500 insider shares for an aggregate purchase price of $25,000. On April 22, 2015, we effectuated a bonus share issue of the Company of 0.03655250836 ordinary shares for each outstanding ordinary share, resulting in an aggregate of 3,874,115 insider shares outstanding and held by our sponsor. Also on April 22, 2015, our four independent directors purchased an aggregate of 92,000 of our ordinary shares, and an entity controlled by Dwight W. Anderson (one of our directors) purchased an aggregate of 346,385 of our ordinary shares. On June 10, 2015, the entity controlled by Mr. Anderson sold 45,994 of its ordinary shares to our sponsor, at the original purchase price, and on the same date we effected a bonus share issue of 0.16666666666667 ordinary shares for each outstanding ordinary share. As a result, our sponsor owned 4,573,461 insider shares, the entity controlled by Mr. Anderson owned 350,457 insider shares, and each of our four independent directors owned 26,833 insider shares. Upon the closing of the IPO, the underwriters exercised their over-allotment option in part and notified us that they would not be exercising the remainder of their over-allotment option. As a result, the initial shareholders forfeited an aggregate of 31,250 ordinary shares. Simultaneously with the consummation of the IPO, our sponsor and an entity controlled by Mr. Anderson, and their designees, purchased an aggregate of 14,050,000 private warrants at a price of $0.50 per warrant (for a total purchase price of $7,025,000). The net proceeds of the IPO plus the proceeds of the sale of the private placement warrants were deposited in the trust account. On June 5, 2017, our shareholders approved the First Extension, which extended the date by which we have to consummate a business combination to October 8, 2017. As of July 31, 2017, following redemptions of 3,031,985 of the Company’s shares in connection with the First Extension, we had approximately $171.9 million in the trust account. On June 6, 2017, in connection with the First Extension, the Company’s Memorandum and Articles of Association were amended and restated and the Company and the trustee entered into a trust amendment, pursuant to which the date on which to commence liquidation of the Trust Account established in connection with the IPO in the event we have not consummated a business combination was extended from June 10, 2017 to October 8, 2017. On October 5, 2017, our shareholders approved the Second Extension, which extended the date by which we have to consummate a business combination until February 5, 2018. As of November 30, 2017, following redemptions of 3,937,943 of the Company’s shares in connection with the Second Extension, we had approximately $133.4 million in the trust account. On October 5, 2017, in connection with the Second Extension, the Company’s Memorandum and Articles of Association were amended and restated and the Company and the trustee entered into a trust amendment, pursuant to which the date on which to commence liquidation of the Trust Account established in connection with the IPO in the event we have not consummated a business combination was extended from October 5, 2017 to February 5, 2018.
The mailing address of Electrum’s principal executive office is Electrum Special Acquisition Corporation, c/o The Electrum Group LLC, 700 Madison Avenue, 5th Floor, New York, New York 10065, and its telephone number is (646) 365-1600.